Insiders BioAtla, Inc.

Equities

BCAB

US09077B1044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.58 ^USD	+1.57%		+18.35%	+4.88%

Mar. 27	HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating	MT
Mar. 26	Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Viatris Projects Lower 2023 Revenue Despite Swinging to Fourth-Quarter Profit	23-02-27	MT
BioAtla President Scott Smith to Leave; Appointed as CEO at Viatris	23-02-27	MT
Viatris names Scott Smith as CEO ahead of planned divestiture of certain businesses	23-02-27	RE
Bioatla, Inc. Announces Resignation of Scott Smith as President	23-02-27	CI
Insider Buy: Bioatla	22-08-15	MT
Bioatla, Inc. Announces Executive Changes, Effective June 16, 2022	22-06-06	CI
Bioatla Appoints Edward L. Williams to Board of Directors	21-12-21	CI
Insider Sell: Bioatla	21-12-08	MT
BioAtla, LLC Appoints Eric Sievers, M.D., as Chief Medical Officer	19-06-28	CI
BioAtla, LLC Announces the Appointment of Scott Smith, as President	18-09-10	CI
BioAtla Appoints Lawrence Fong as Scientific Advisor	18-07-24	CI
BioAtla Appoints James Allison and Padmanee Sharma as Scientific Advisors	17-11-16	CI
BioAtla, LLC Appoints Yong Ben as Chief Medical Officer	17-05-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer